Novo Nordisk presented two studies at The Liver Meeting 2026 that used Truveta Data to examine changes in liver enzymes, weight, and blood sugar among adults with metabolic dysfunction-associated steatohepatitis (MASH) who started semaglutide 2.4 mg (Wegovy).
In PLATINUM-Truveta, adults...
Click on the "Follow" button below and you'll get the latest news from Truveta via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
Truveta title: EHR data and analytics | Truveta